About Inso Bio
Inso Bio is a private company based in Ithaca, New York. It has reported $2,525,000 raised in two offerings on Form D since February 2022. Its chief executive is Harvey Tian.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Apr 10, 2026 | $750,000of $3.0M target | 9 | $83,333 | Debt, Options, Securities on exercise, Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be acquired upon such conversion.Rule 506(b) | Form D ↗ |
| Feb 11, 2022 | Feb 25, 2022 | $1,775,000of $2.2M target | 4 | $443K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $2,525,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Inso Bio's Form D filed Apr 10, 2026.
AB
HT